Novel Protein Biomarkers of Monoamine Metabolism Defects Correlate with Disease Severity

Tristán‐Noguero, Alba; Borràs, Eva; Molero-Luís, Marta; Wassenberg, Tessa; M. A. Peters, Tessa; M. Verbeek, Marcel; A.A.P. Willemsen, Michèl; Opladen, Thomas; Jeltsch, Kathrin; Pons, Roser; Thöny, Beat; Horváth, Gabriella; Yapıcı, Zühal; Friedman, Jennifer; Hyland, Keith; Agosta, Guillermo; López‐Laso, Eduardo; Artuch, Rafael; Sabidó, Eduard; García‐Cazorla, Àngels

doi:10.1002/mds.28362

Public

Novel Protein Biomarkers of Monoamine Metabolism Defects Correlate with Disease Severity

Published in Movement Disorders • Nov 5, 2020

Authors:

Alba Tristán‐Noguero

Eva Borràs

Marta Molero-Luís

Abstract

BACKGROUND: Genetic defects of monoamine neurotransmitters are rare neurological diseases amenable to treatment with variable response. They are major causes of early parkinsonism and other spectrum of movement disorders including dopa-responsive dystonia. OBJECTIVES: The objective of this study was...

Subject

Monoamine neurotransmitter

Internal medicine

Dopaminergic

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!